دورية أكاديمية
Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes.
العنوان: | Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. |
---|---|
المؤلفون: | Vogel JP; Maternal, Child and Adolescent Health Program, Burnet Institute, Melbourne, VIC 3004, Australia. Electronic address: joshua.vogel@burnet.edu.au., Ramson J; Maternal, Child and Adolescent Health Program, Burnet Institute, Melbourne, VIC 3004, Australia., Darmstadt GL; Prematurity Research Center, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA., Qureshi ZP; Department of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya., Chou D; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland., Bahl R; Department of Maternal, Newborn, Child and Adolescent Health and Ageing, WHO, Geneva, Switzerland., Oladapo OT; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland. |
المصدر: | The Lancet. Global health [Lancet Glob Health] 2022 Dec; Vol. 10 (12), pp. e1707-e1708. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [England] : Elsevier Ltd. 2013- |
مواضيع طبية MeSH: | Tocolysis* , Premature Birth*/prevention & control, Infant, Newborn ; Female ; Pregnancy ; Humans ; Adrenal Cortex Hormones/therapeutic use ; Gestational Age ; World Health Organization |
مستخلص: | Competing Interests: We declare no competing interests. The WHO guideline development panel that formulated the antenatal corticosteroids and tocolytics recommendations was an independent, international panel of experts convened by WHO. The panel was co-chaired by GLD and ZPQ. JPV was project manager, and RB and OTO were project coordinators for WHO ACTION-I trial. JPV, RB, and OTO did not take part in the formulation of the recommendations. We would like to acknowledge that this Comment was updated by the Department of Sexual and Reproductive Health and Research and the Department of Maternal, Newborn, Child and Adolescent Health and Ageing at WHO in Geneva. WHO acknowledges the contributions of the many individuals and organisations to the development of these recommendations, including systematic reviewers, members of the Guideline Development Group, and other collaborators. |
References: | Cochrane Database Syst Rev. 2022 Aug 10;8:CD014978. (PMID: 35947046) Am J Obstet Gynecol. 2018 Sep;219(3):301.e1-301.e16. (PMID: 29758177) JAMA Pediatr. 2017 Jul 1;171(7):678-686. (PMID: 28505223) N Engl J Med. 2020 Dec 24;383(26):2514-2525. (PMID: 33095526) Lancet. 2015 Feb 14;385(9968):629-639. (PMID: 25458726) Lancet Glob Health. 2022 Dec;10(12):e1707-e1708. (PMID: 36400080) Cochrane Database Syst Rev. 2022 Apr 4;4:CD003935. (PMID: 35377461) Cochrane Database Syst Rev. 2020 Dec 25;12:CD004454. (PMID: 33368142) |
معلومات مُعتمدة: | 001 International WHO_ World Health Organization |
المشرفين على المادة: | 0 (Adrenal Cortex Hormones) |
تواريخ الأحداث: | Date Created: 20221118 Date Completed: 20221122 Latest Revision: 20221225 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC9681658 |
DOI: | 10.1016/S2214-109X(22)00434-X |
PMID: | 36400080 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!